This week, we chat with a visionary on a quest to empower women to become 'really f***ing rich.' Cindy Eckert, the force behind Sprout Pharmaceuticals, is not only driving this mission but also enhancing our intimate lives. Her company, which she sold for $1 billion and later reacquired for a fraction of that, introduced Addyi—the first FDA-approved treatment for low sexual desire in women.
Our discussion covers topics like hormones, the pharmaceutical industry, negotiation tactics, and addressing sexism. Her mantra? 'Kill them with competence.' It's an essential listen. In our Mailbag segment, we tackle questions about credit cards, student loans, and various financial decisions. Plus, in Thrive, we explore alarming findings on the little white lies women share when they earn more than their partners.
